SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-083617
Filing Date
2013-11-12
Accepted
2013-11-12 16:07:24
Documents
4
Period of Report
2013-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-24080_18k.htm 8-K 26669
2 EX-99.1 a13-24080_1ex99d1.htm EX-99.1 220017
3 GRAPHIC g240801mm01i001.jpg GRAPHIC 3190
4 GRAPHIC g240801mm01i002.jpg GRAPHIC 2058
  Complete submission text file 0001104659-13-083617.txt   255474
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 131210219
SIC: 2834 Pharmaceutical Preparations